These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24807243)

  • 21. Morphological and quantitative analysis of vascular wall and neointimal hyperplasia after coronary stenting: comparison of bare-metal and sirolimus-eluting stents using optical coherence tomography.
    Goto I; Itoh T; Kimura T; Fusazaki T; Matsui H; Sugawara S; Komuro K; Nakamura M
    Circ J; 2011; 75(7):1633-40. PubMed ID: 21628836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
    Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
    Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.
    Kim BK; Kim JS; Oh C; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):705-14. PubMed ID: 21626042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: A preliminary observation.
    Fukuhara K; Okura H; Kume T; Yamada R; Neishi Y; Uemura S
    J Cardiol; 2016 May; 67(5):437-41. PubMed ID: 26276105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.
    Kwon SW; Kim BK; Kim TH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2011 Feb; 161(2):367-72. PubMed ID: 21315221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic neointimal pattern after drug-eluting stent implantation defined by optical coherence tomography.
    Yamamoto E; Xing L; Higuma T; Minami Y; Bryniarski K; Zanchin T; Wang Z; Aguirre AD; Lee H; Jang IK
    Coron Artery Dis; 2017 Nov; 28(7):557-563. PubMed ID: 28704243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry.
    Yonetsu T; Kato K; Kim SJ; Xing L; Jia H; McNulty I; Lee H; Zhang S; Uemura S; Jang Y; Kang SJ; Park SJ; Lee S; Yu B; Kakuta T; Jang IK
    Circ Cardiovasc Imaging; 2012 Sep; 5(5):660-6. PubMed ID: 22798521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
    Tanaka N; Terashima M; Rathore S; Itoh T; Habara M; Nasu K; Kimura M; Itoh T; Kinoshita Y; Ehara M; Tsuchikane E; Asakura K; Asakura Y; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1074-9. PubMed ID: 20965467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of neointimal tissue morphology on vascular response to balloon angioplasty in lesions with in-stent restenosis after drug-eluting stent deployment: an optical coherence tomography analysis.
    Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Shimatani Y; Hasegawa K; Ishibuchi K; Tamaru H; Ishii R; Yasuda S; Taniguchi Y; Nakabayashi S; Kusumoto H; Higashino Y
    Heart Vessels; 2020 Sep; 35(9):1193-1200. PubMed ID: 32253529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry.
    Kobayashi T; Sotomi Y; Suzuki S; Hamanaka Y; Nakatani S; Dijkstra J; Onuma Y; Serruys PW; Sakata Y; Hirayama A; Higuchi Y
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):205-215. PubMed ID: 31673850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empagliflozin attenuates neointimal hyperplasia after drug-eluting-stent implantation in patients with type 2 diabetes.
    Hashikata T; Ikutomi M; Jimba T; Shindo A; Kakuda N; Katsushika S; Yokoyama M; Kishi M; Sato T; Matsushita M; Ohnishi S; Yamasaki M
    Heart Vessels; 2020 Oct; 35(10):1378-1389. PubMed ID: 32399662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
    Yoshimura T; Tanaka A; Mori N; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):742-9. PubMed ID: 24497273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
    Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
    EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, multicenter, randomized OCT study of early neointimal condition at first and second months after BuMA Supreme stent versus XIENCE stent implantation in high-bleeding-risk coronary artery disease patients: study protocol for a randomized controlled trial.
    Li B; Jin QH; Chen YD; Wang CQ; Shi B; Su X; Fu GS; Wu YQ; Zhou XC; Yuan ZY
    Trials; 2019 Jun; 20(1):335. PubMed ID: 31174600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
    Legutko J; Gil RJ; Buszman PE; Kaluza GL; Mintz GS; Roleder T; Krol M; Wojdyla R; Pawlowski T; Brzezinski M; Kondys M; Skwarna B; Jakala J; Zasada W; Partyka L; Dudek D
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):302-309. PubMed ID: 29027737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.